Skip to main content

and
  1. Article

    Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach

    Neoadjuvant treatment is recommended for large GISTs due to their friability and risk of extensive operations; however, studies on the indications and long-term results of this approach are lacking.

    Seong-Ho Kong, Yukinori Kurokawa, Jeong-Hwan Yook, Haruhiko Cho in Gastric Cancer (2023)

  2. Article

    A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer

    The aim of this study was to establish the efficacy and safety of doxifluridine and docetaxel for patients with advanced or recurrent gastric cancer.

    Takaki Yoshikawa, Akira Tsuburaya, Ken Shimada, Atsushi Sato in Gastric Cancer (2009)